文献
J-GLOBAL ID:202002230727405194
整理番号:20A0203254
血清テネイシンCは,II型糖尿病患者における主要有害心血管イベントおよび死亡の増加と独立して関連する【JST・京大機械翻訳】
Serum Tenascin-C is independently associated with increased major adverse cardiovascular events and death in patients with type II diabetes
著者 (9件):
Gellen B.
(ELSAN-Polyclinique de Poitiers, Poitiers, France)
,
Thorin-Trescases N.
(Department of Surgery, Faculty of Medicine, Universite de Montreal, Montreal Heart Institute, Montreal, Canada)
,
Thorin E.
(Department of Surgery, Faculty of Medicine, Universite de Montreal, Montreal Heart Institute, Montreal, Canada)
,
Gand E.
(CHU de Poitiers Centre d’Investigation Clinique, Poitiers, France)
,
Sosner P.
(CHU de Poitiers Centre d’Investigation Clinique, Poitiers, France)
,
Brishoual S.
(CHU de Poitiers Centre d’Investigation Clinique, Poitiers, France)
,
Fraty M.
(CHU de Poitiers Centre d’Investigation Clinique, Poitiers, France)
,
Hadjadj S.
(CHU de Poitiers Centre d’Investigation Clinique, Poitiers, France)
,
Saulnier P.J.
(CHU de Poitiers Centre d’Investigation Clinique, Poitiers, France)
資料名:
Archives of Cardiovascular Diseases Supplements
(Archives of Cardiovascular Diseases Supplements)
巻:
12
号:
1
ページ:
156
発行年:
2020年
JST資料番号:
W2889A
ISSN:
1878-6480
資料種別:
逐次刊行物 (A)
記事区分:
短報
発行国:
オランダ (NLD)
言語:
英語 (EN)